Friday, February 1, 2019
Trovagene Inc. (TROV)
PoC Capital Agreement to Fund Colorectal Cancer Trial
Ahu Demir, Ph.D., Biotechnology Research Analyst, Noble Capital Markets, Inc.
RATING: OUTPERFORM
Research – Trovagene (TROV) – Funding for trial
Looking for the next apple? This is the orchard.